Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
72.15 CHF | +0.07% | -2.69% | +42.24% |
26/04 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
25/04 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
Evolution of the average Target Price on Cosmo Pharmaceuticals N.V.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cosmo Pharmaceuticals N.V.
Berenberg Bank | |
Research Capital |
EPS Revisions
- Stock Market
- Equities
- COPN Stock
- Consensus Cosmo Pharmaceuticals N.V.